Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,971,060
+$4,209,433 QoQ
Shares Held
383,775
+16.0% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 435 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Jun 30, 2024CallValue
$26,505
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. VKTX ranks #95 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in VKTX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,971,060 | 383,775 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,761,627 | 330,720 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $12,195,039 | 346,647 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,196,880 | 578,268 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $13,906,457 | 524,772 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,735,293 | 361,710 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,548,809 | 361,551 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $26,769,555 | 422,833 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,505 | 500 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $22,835,752 | 430,782 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $33,818,030 | 412,415 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $41,000 | 500 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $14,341,292 | 770,623 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,663,472 | 692,274 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,561,255 | 404,766 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $108,607 | 6,700 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $13,150,918 | 789,845 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $1,138,860 | 68,400 | Call | Defined | 2023-05-12 | |
| 2022-12-31 | $910,860 | 96,900 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $320,360 | 117,780 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $349,286 | 120,861 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $151,689 | 50,563 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $251,256 | 54,621 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,837,412 | 292,582 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,663,677 | 277,743 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,460,967 | 389,086 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,410,976 | 250,618 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,745,519 | 299,918 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,141,461 | 297,013 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,314,887 | 280,959 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||